Mark D. Reisbig

624 total citations
15 papers, 492 citations indexed

About

Mark D. Reisbig is a scholar working on Molecular Medicine, Physiology and Endocrinology. According to data from OpenAlex, Mark D. Reisbig has authored 15 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Medicine, 4 papers in Physiology and 4 papers in Endocrinology. Recurrent topics in Mark D. Reisbig's work include Antibiotic Resistance in Bacteria (8 papers), Salmonella and Campylobacter epidemiology (4 papers) and Pain Mechanisms and Treatments (3 papers). Mark D. Reisbig is often cited by papers focused on Antibiotic Resistance in Bacteria (8 papers), Salmonella and Campylobacter epidemiology (4 papers) and Pain Mechanisms and Treatments (3 papers). Mark D. Reisbig collaborates with scholars based in United States, Canada and South Africa. Mark D. Reisbig's co-authors include Nancy D. Hanson, Deirdre L. Church, Johann Pitout, Kenneth S. Thomson, Ellen Smith Moland, Jennifer Ann Black, Daniel R. Kirkpatrick, Devendra K. Agrawal, Daniel J. Wolter and Dan Gregson and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Mark D. Reisbig

14 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark D. Reisbig United States 11 313 143 102 102 93 15 492
Jorge Hernández Sweden 13 261 0.8× 109 0.8× 96 0.9× 192 1.9× 45 0.5× 21 552
Ana Valverde Portugal 9 468 1.5× 227 1.6× 97 1.0× 157 1.5× 72 0.8× 22 660
Véronique Dupouy France 12 193 0.6× 68 0.5× 138 1.4× 145 1.4× 103 1.1× 25 500
Farah Al‐Marzooq United Arab Emirates 17 187 0.6× 64 0.4× 206 2.0× 48 0.5× 66 0.7× 49 669
Agnieszka M. Wiklendt Australia 10 167 0.5× 58 0.4× 75 0.7× 59 0.6× 36 0.4× 11 555
Aycan Gündoğdu Türkiye 14 158 0.5× 105 0.7× 192 1.9× 67 0.7× 22 0.2× 38 504
Renchi Fang China 15 268 0.9× 101 0.7× 414 4.1× 52 0.5× 90 1.0× 20 869
Ko-Chiang Hsia Taiwan 9 171 0.5× 90 0.6× 158 1.5× 38 0.4× 53 0.6× 14 340
Bahman Mirzaei Iran 15 218 0.7× 76 0.5× 331 3.2× 39 0.4× 38 0.4× 61 669
Hoan Nguyen United States 8 229 0.7× 67 0.5× 269 2.6× 42 0.4× 127 1.4× 17 597

Countries citing papers authored by Mark D. Reisbig

Since Specialization
Citations

This map shows the geographic impact of Mark D. Reisbig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Reisbig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Reisbig more than expected).

Fields of papers citing papers by Mark D. Reisbig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Reisbig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Reisbig. The network helps show where Mark D. Reisbig may publish in the future.

Co-authorship network of co-authors of Mark D. Reisbig

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Reisbig. A scholar is included among the top collaborators of Mark D. Reisbig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Reisbig. Mark D. Reisbig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kirkpatrick, Daniel R., et al.. (2016). Pain transduction: a pharmacologic perspective. Expert Review of Clinical Pharmacology. 9(8). 1069–1080. 34 indexed citations
2.
Kirkpatrick, Daniel R., et al.. (2016). Transmission pathways and mediators as the basis for clinical pharmacology of pain. Expert Review of Clinical Pharmacology. 9(10). 1363–1387. 11 indexed citations
3.
4.
5.
Kirkpatrick, Daniel R., et al.. (2015). Therapeutic Basis of Clinical Pain Modulation. Clinical and Translational Science. 8(6). 848–856. 45 indexed citations
6.
Kirkpatrick, Daniel R., et al.. (2015). Arterial Catheterization and Infection: Toll‐like Receptors in Defense against Microorganisms and Therapeutic Implications. Clinical and Translational Science. 8(6). 857–870. 7 indexed citations
7.
Kirkpatrick, Daniel R., et al.. (2014). Effect of sedative-hypnotics, anesthetics and analgesics on sleep architecture in obstructive sleep apnea. Expert Review of Clinical Pharmacology. 7(6). 787–806. 8 indexed citations
8.
Geyer, Chelsie N., Mark D. Reisbig, & Nancy D. Hanson. (2012). Development of a TaqMan Multiplex PCR Assay for Detection of Plasmid-Mediated AmpC β-Lactamase Genes. Journal of Clinical Microbiology. 50(11). 3722–3725. 20 indexed citations
9.
Lister, Philip, et al.. (2006). Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs. Journal of Antimicrobial Chemotherapy. 57(5). 999–1003. 29 indexed citations
10.
Reisbig, Mark D. & Nancy D. Hanson. (2004). Promoter Sequences Necessary for High-Level Expression of the Plasmid-AssociatedampCβ-Lactamase GeneblaMIR-1. Antimicrobial Agents and Chemotherapy. 48(11). 4177–4182. 15 indexed citations
11.
Reisbig, Mark D.. (2003). Factors influencing gene expression and resistance for Gram-negative organisms expressing plasmid-encoded ampC genes of Enterobacter origin. Journal of Antimicrobial Chemotherapy. 51(5). 1141–1151. 38 indexed citations
12.
Pitout, Johann, Mark D. Reisbig, Linda Chui, et al.. (2003). Association between Handling of Pet Treats and Infection with Salmonella enterica Serotype Newport Expressing the AmpC β-Lactamase, CMY-2. Journal of Clinical Microbiology. 41(10). 4578–4582. 84 indexed citations
13.
Pitout, Johann, et al.. (2003). Modification of the Double-Disk Test for Detection of Enterobacteriaceae Producing Extended-Spectrum and AmpC β-Lactamases. Journal of Clinical Microbiology. 41(8). 3933–3935. 68 indexed citations
14.
Reisbig, Mark D.. (2002). The ACT-1 plasmid-encoded AmpC beta-lactamase is inducible: detection in a complex beta-lactamase background. Journal of Antimicrobial Chemotherapy. 49(3). 557–560. 34 indexed citations
15.
Moland, Ellen Smith, et al.. (2002). Occurrence of Newer β-Lactamases in Klebsiella pneumoniae Isolates from 24 U.S. Hospitals. Antimicrobial Agents and Chemotherapy. 46(12). 3837–3842. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jorge Hernández Breakdown of academic impact, for papers by Ana Valverde Breakdown of academic impact, for papers by Véronique Dupouy Breakdown of academic impact, for papers by Farah Al‐Marzooq Breakdown of academic impact, for papers by Agnieszka M. Wiklendt Breakdown of academic impact, for papers by Aycan Gündoğdu Breakdown of academic impact, for papers by Renchi Fang Breakdown of academic impact, for papers by Ko-Chiang Hsia Breakdown of academic impact, for papers by Bahman Mirzaei Breakdown of academic impact, for papers by Hoan Nguyen
Rankless by CCL
2026